Azad, A., Badillo, M. A., Dong, Q., Morgans, A. K., Rathkopf, D., Runcie, K., Zhang, T., Gotto, G., Merseburger, A. S., Santos, A. D., Shopeju, S., Bhaumik, A., Mundle, S. D., McCarthy, S., Agarwal, N. (2025). Deep prostate-specific antigen (PSA) decline among early participants (pts) in LIBERTAS, a phase 3 study of apalutamide (APA) plus continuous versus intermittent androgen deprivation therapy (ADT) in metastatic castration-sensitive prostate cancer (mCSPC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.5_suppl.147